Literature DB >> 3517024

The present status of erythrocyte spectrin structure: the 106-residue repetitive structure is a basic feature of an entire class of proteins.

D W Speicher.   

Abstract

Spectrin, the major component of the erythroid membrane skeleton, is a long, asymmetrical rodlike protein that interacts with several other proteins to form a two-dimensional membrane skeleton. Progress in several laboratories over the past few years including substantial partial peptide and nucleotide sequence determination has greatly enhanced our knowledge of the structural properties of this large molecule (heterodimer = 465,000 daltons). The alpha and beta subunits are homologous with approximately 30% identity. They are aligned in an antiparallel side-to-side orientation with the amino- and carboxy-termini near opposite physical ends of the molecule. The predominant structural feature elucidated from sequencing this large molecule is the nearly universal occurrence in both subunits of a single type of repetitive structure. The periodicity of this homologous structure is exactly 106 amino acid residues. As many as 36 homologous, but nonidentical, repeats exist and comprise more than 90% of the mass of the heterodimer. Each of these repetitive units is folded into a triple-stranded structure that is highly helical. Peptide maps, antibody crossreactivity, peptide sequence analysis, and more recently nucleic acid sequences have defined several major properties of the erythroid molecule and related proteins in other tissues. Tissue-specific spectrins have the same 106-residue repetitive structure and show sequence homology to erythroid spectrin.

Mesh:

Substances:

Year:  1986        PMID: 3517024     DOI: 10.1002/jcb.240300306

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

1.  The complete sequence of Drosophila beta-spectrin reveals supra-motifs comprising eight 106-residue segments.

Authors:  T J Byers; E Brandin; R A Lue; E Winograd; D Branton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

2.  Spectrin folding versus unfolding reactions and RBC membrane stiffness.

Authors:  Qiang Zhu; Robert J Asaro
Journal:  Biophys J       Date:  2007-12-07       Impact factor: 4.033

3.  A central region of Ku80 mediates interaction with Ku70 in vivo.

Authors:  R B Cary; F Chen; Z Shen; D J Chen
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

4.  On the structure of erythrocyte spectrin in partially expanded membrane skeletons.

Authors:  A M McGough; R Josephs
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  Comparison of nonerythroid alpha-spectrin genes reveals strict homology among diverse species.

Authors:  T L Leto; D Fortugno-Erikson; D Barton; T L Yang-Feng; U Francke; A S Harris; J S Morrow; V T Marchesi; E J Benz
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

6.  Elasticity of the human red cell membrane skeleton. Effects of temperature and denaturants.

Authors:  B G Vertessy; T L Steck
Journal:  Biophys J       Date:  1989-02       Impact factor: 4.033

7.  Interaction of tacrine and velnacrine with neocortical synaptosomal membranes: relevance to Alzheimer's disease.

Authors:  D A Butterfield; K Hensley; N Hall; S Umhauer; J Carney
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

8.  A tethered adhesive particle model of two-dimensional elasticity and its application to the erythrocyte membrane.

Authors:  S Feng; R C MacDonald
Journal:  Biophys J       Date:  1996-02       Impact factor: 4.033

9.  Sequence similarity of the amino-terminal domain of Drosophila beta spectrin to alpha actinin and dystrophin.

Authors:  T J Byers; A Husain-Chishti; R R Dubreuil; D Branton; L S Goldstein
Journal:  J Cell Biol       Date:  1989-10       Impact factor: 10.539

10.  Phasing the conformational unit of spectrin.

Authors:  E Winograd; D Hume; D Branton
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.